Stock News Releases and Press Releases OTCMKTS, NASDAQ and NYSE Markets

2024-07-25 11:55:26 ET This innovative company is dedicated to revolutionizing %Healthcare and supplementation, empowering individuals to live their best lives through nutritional and groundbreaking medical treatments. And shares are trading up on news of a line of credit. %ADIANu...

The NASDAQ Composite dropped for a second day Thursday as Wall Street continued its rotation out of technology stocks. The Dow Jones Industrials recovered 175.76 points to 40,029.63. The S&P 500 index subtracted 2.99 points to 5,424.14. The tech-heavy NASDAQ lost another 86.89 poi...

2024-07-25 11:48:29 ET Shares of AstraZeneca (NASDAQ: AZN) were sliding 3.2% lower as of 10:57 a.m. ET on Thursday. The decline came after the British drugmaker announced its second-quarter results. AstraZeneca reported total revenue in Q2 of $12.9 billion, up 13% year over year...

H1 2024 Key figures 2 › Revenue of EUR 3,021.7 million in the first half of 2024, up 4.0% year on year and up 9.2% organically (including 10.4% in the second quarter) › Adjusted operating profit of EUR 451.9 million, up 4.1% versus EUR 434.2 million in H1 2023, represent...

2024-07-25 11:45:11 ET Image source: The Motley Fool. AstraZeneca Plc (NASDAQ: AZN) Q2 2024 Earnings Call Jul 25, 2024 , 6:45 a.m. ET Operator Continue reading For further details see: AstraZeneca Plc (AZN) Q2 2024 Earnings Call Transcript

2024-07-25 11:45:00 ET Rate cuts by the Bank of Canada are putting a new tailwind behind top TSX dividend stocks. Income investors are wondering which dividend-growth stocks are still undervalued and good to buy for a self-directed portfolio focused on passive income and long-term t...

2024-07-25 11:45:00 ET Rate cuts by the Bank of Canada are putting a new tailwind behind top TSX dividend stocks. Income investors are wondering which dividend-growth stocks are still undervalued and good to buy for a self-directed portfolio focused on passive income and long-term t...

2024-07-25 11:45:00 ET Rate cuts by the Bank of Canada are putting a new tailwind behind top TSX dividend stocks. Income investors are wondering which dividend-growth stocks are still undervalued and good to buy for a self-directed portfolio focused on passive income and long-term t...

H1 2024 revenue Half-yearly activity H1 revenue: €419.2m, up 11.8% at CER 1 , including an acceleration in Q2 (+14.5%) This acceleration was driven by continued catch-up in the Americas, the normalisation of orders in France and MRI sales Annual targets conf...

Annual revenue: $63.2 million, gross profit: $30.2 million, net income p/s: $(0.0045) 4Q2024 revenue: $15.7 million, gross profit: $6.6 million, net income p/s: $0.0014 Total liabilities decreased to $31.2 million in 4Q2024 from $46 million in 3Q2024 Exxe Group, Inc. (...